Skip to content

Dr. Dirk Vervloessem

Active Private limited companyfounded 2006active for 20 yearsNorbertijnerlei 4, 2570 DuffelKBO/BCE: BE 0880.148.702 #5 oldest company in Duffel, Health and social work sector

Lifetime

19 annual accounts with figures on one time axis
peak of €190,097 in 2025
€190,097▲ 24.9%
lowest -€48,049 in 2008
€128,576▲ 30.7%
peak of €208,322 in 2016
€190,431▲ 34.2%
€64,634▲ 53.9%
Board1 name since 2016
1 director
Documentsfilings and deeds
22-08-202622 days late
2025micro format
Gross margin from €152,184 to €190,097Result from €98,399 to €128,576Dividend €80,000Equity from €141,854 to €190,431Debts from €42,005 to €64,634Investments €34,434

Key points

from the 2025 annual accounts

Equity

€190,431 ▲ 34.2%
141,8542024+128,576Profit-80,000Dividend190,4312025

Dr. Dirk Vervloessem paid out €80,000 in dividends. That is 62% of the 2025 profit.

Investments

€34,434 3.0 times depreciation
2021202220232025

Green is investment, beige is depreciation.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Four of the last ten came late. The 2019 accounts came in latest, 54 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as Dr. Dirk Vervloessem has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for Dr. Dirk Vervloessem. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0880148702
resigns as director reappointed as director · Director discharge: · General meeting of 24-07-2024 · Gazette deed
reappointed as manager General meeting of 01-03-2016 · Gazette deed
Incorporation published on 03-04-2006 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Dirk Vervloessem Duffel - - 74.7% -
Dr BETEK Ans - - 39.8% -
DR. NICO COENEN Hasselt - - 84.9% -
CARDIOLOGY SOCIETY DEVELOPMENT Forest €725,873 23.9% -25.0% -
DOKTER LUCAS VERKINDEREN Antwerp - - 72.5% -
Dokter P. Bernaerts Kapellen - - 92.5% -
DOKTER S.K.C. GOOSSENS Brasschaat €528,382 28.6% 88.8% -

These companies have the same main activity as Dr. Dirk Vervloessem: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €264,000 and €306,000, founded between 2002 and 2008.

Official details

Source: KBO
Status
Active since 16-03-2006Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 06-11-2024
Company details

Annual accounts 2025

≈ €350,000estimated
€255,065▲ 38.7%
Filing
Filed on 22-08-2026
Financials

Insights on Dr. Dirk Vervloessem

Dr. Dirk Vervloessem files the micro format. That format states no turnover. The gross margin rose from €110,289 in 2007 to €190,097 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Dirk Vervloessem

What is the company number of Dr. Dirk Vervloessem?
The company number of Dr. Dirk Vervloessem is 0880.148.702. The VAT number is the same number with BE in front: BE 0880.148.702.
Where is Dr. Dirk Vervloessem based?
The registered office is at Norbertijnerlei 4, 2570 Duffel.Company details
What does Dr. Dirk Vervloessem do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Dirk Vervloessem?
Dr. Dirk Vervloessem is a private limited company (BV).
When was Dr. Dirk Vervloessem founded?
Dr. Dirk Vervloessem was founded on 16-03-2006.
Is Dr. Dirk Vervloessem still active?
Yes, Dr. Dirk Vervloessem is an active enterprise in the KBO register.
What is the turnover of Dr. Dirk Vervloessem?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €190,097 and 40 comparable companies (NACE 86220). It probably lies between €300,000 and €470,000.Financials
Is Dr. Dirk Vervloessem profitable?
In financial year 2025, Dr. Dirk Vervloessem made a profit of €128,576.
Where can I find the annual accounts of Dr. Dirk Vervloessem?
Dr. Dirk Vervloessem filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Dirk Vervloessem due?
Dr. Dirk Vervloessem must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.